Product Information
IRBESARTAN 150 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.1176 per EA under NDC 59746044830. Its NADAC has been published 483 times since Dec 9, 2015.
Strength
150 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746044830
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203534On Market Since
2/24/2015
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 150 MG TABLET has been published 483 times since Dec 9, 2015, and over the history we have for it it has declined 34.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1176 per EA |
|---|---|
| All-time high | $0.3249 (Oct 16, 2019) |
| All-time low | $0.0990 (Nov 20, 2024) |
| Median price | $0.1778 |
| Average price | $0.1855 |
| Largest weekly change | +25.9% (Jun 19, 2024) |
| Weeks tracked | 483 |
| Tracking since | Dec 9, 2015 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 150 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.1176 per EA (NDC 59746044830), effective Mar 5, 2025.
How has the price of IRBESARTAN 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 150 MG TABLET has declined 34.0%. It has been tracked across 483 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 150 MG TABLET?
Since Dec 9, 2015, the NADAC for IRBESARTAN 150 MG TABLET has ranged from a low of $0.0990 (Nov 20, 2024) to a high of $0.3249 (Oct 16, 2019), with a median of $0.1778 per EA.
Are there cheaper alternatives to IRBESARTAN 150 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IRBESARTAN 150 MG TABLET, is $0.1111 per EA — about 6% below IRBESARTAN 150 MG TABLET.
Who manufactures IRBESARTAN 150 MG TABLET?
IRBESARTAN 150 MG TABLET (NDC 59746044830) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification